In our diverse cohort of 36 patients diagnosed with AS through genetic testing, we identified that subjects with COL4A4 variants and those with missense variants had significantly better kidney survival, whereas those with COL4A3 variants and those with clinically significant hearing loss had worse renal prognoses. The gene discussed is COL4A3; the disease is hearing loss disorder.